ClinicalTrials.gg
Sign In

DrugBiological

Anti-CNTN4 Monoclonal Antibody GENA-104A16 clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2022

How studies write it

Studies that test it under each name

Written with another drug

BI-1607
2

Studies by the year they started

3 studies that test it; most in 2024 (2)

Studies that test Anti-CNTN4 Monoclonal Antibody GENA-104A16, by start year
YearStudies
20221
20242

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Uveal Melanoma
1

Who runs them

Industry 3 · Other 0

BioInvent International AB (2) · Genome & Company (1)

Often tested with

Tested in the same studies.

Anti-CD32B Monoclonal Antibody BI-1607 (2) · Pembrolizumab (1) · Ipilimumab (1) · Trastuzumab (1)

Studies

Open first, then newest update. How each study uses Anti-CNTN4 Monoclonal Antibody GENA-104A16 is read from its arms, and is right about nine times in ten.

Testing it · 3